Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.

Thomas S, Pütter C, Weber S, Bornfeld N, Lohmann DR, Zeschnigk M.

Br J Cancer. 2012 Mar 13;106(6):1171-6. doi: 10.1038/bjc.2012.54. Epub 2012 Feb 21.

2.

HSP-27 protein expression in uveal melanoma: correlation with predicted survival.

Jmor F, Kalirai H, Taktak A, Damato B, Coupland SE.

Acta Ophthalmol. 2012 Sep;90(6):534-9. doi: 10.1111/j.1755-3768.2010.02038.x. Epub 2010 Nov 26.

3.

Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.

Cassoux N, Rodrigues MJ, Plancher C, Asselain B, Levy-Gabriel C, Lumbroso-Le Rouic L, Piperno-Neumann S, Dendale R, Sastre X, Desjardins L, Couturier J.

Br J Ophthalmol. 2014 Jun;98(6):769-74. doi: 10.1136/bjophthalmol-2013-303867. Epub 2013 Oct 29.

4.

Cytogenetics of uveal melanoma: a 7-year clinical experience.

Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P.

Ophthalmology. 2007 Oct;114(10):1925-31. Epub 2007 Aug 27.

PMID:
17719643
5.

Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.

van den Bosch T, van Beek JG, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, de Klein A, Kiliç E.

Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2668-74. doi: 10.1167/iovs.11-8697.

PMID:
22427574
6.

Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.

Nareyeck G, Zeschnigk M, Prescher G, Lohmann DR, Anastassiou G.

Exp Eye Res. 2006 Oct;83(4):858-64. Epub 2006 Jun 5. Review.

PMID:
16750193
7.

The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma.

van Beek JG, Koopmans AE, Vaarwater J, de Rooi JJ, Paridaens D, Naus NC, de Klein A, Verdijk RM, Kiliç E.

Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1284-91. doi: 10.1167/iovs.13-13670.

8.

Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.

Abdel-Rahman MH, Cebulla CM, Verma V, Christopher BN, Carson WE 3rd, Olencki T, Davidorf FH.

Exp Eye Res. 2012 Jul;100:26-31. doi: 10.1016/j.exer.2012.04.010. Epub 2012 May 5.

9.

Prognostic implications of monosomy 3 in uveal melanoma.

Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R.

Lancet. 1996 May 4;347(9010):1222-5.

PMID:
8622452
10.

Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.

Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK.

Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1008-11.

PMID:
12601021
11.

MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.

Larsen AC, Holst L, Kaczkowski B, Andersen MT, Manfé V, Siersma VD, Kolko M, Kiilgaard JF, Winther O, Prause JU, Gniadecki R, Heegaard S.

Acta Ophthalmol. 2014 Sep;92(6):541-9. doi: 10.1111/aos.12322. Epub 2013 Dec 24.

12.

Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis.

Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC.

Genes Chromosomes Cancer. 1997 May;19(1):22-8.

PMID:
9135991
13.

Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.

Triozzi PL, Elson P, Aldrich W, Achberger S, Tubbs R, Biscotti CV, Singh AD.

Melanoma Res. 2013 Feb;23(1):1-7. doi: 10.1097/CMR.0b013e32835b7154.

PMID:
23196330
14.

Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.

Lederman M, Meir T, Zeschnigk M, Pe'er J, Chowers I.

Curr Eye Res. 2008 Oct;33(10):876-84. doi: 10.1080/02713680802382989.

PMID:
18853322
15.

Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.

Bronkhorst IH, Maat W, Jordanova ES, Kroes WG, Schalij-Delfos NE, Luyten GP, Jager MJ.

Arch Pathol Lab Med. 2011 Aug;135(8):1042-7. doi: 10.5858/2010-0477-OAR1.

PMID:
21809997
16.

Clinical and cytogenetic analyses in uveal melanoma.

Kilic E, van Gils W, Lodder E, Beverloo HB, van Til ME, Mooy CM, Paridaens D, de Klein A, Luyten GP.

Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3703-7.

PMID:
16936076
17.

Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.

Maat W, Ly LV, Jordanova ES, de Wolff-Rouendaal D, Schalij-Delfos NE, Jager MJ.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):505-10. doi: 10.1167/iovs.07-0786.

PMID:
18234992
18.

Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.

Cross NA, Ganesh A, Parpia M, Murray AK, Rennie IG, Sisley K.

Eye (Lond). 2006 Apr;20(4):476-81.

PMID:
15920570
19.

Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.

Papastefanou VP, Islam S, Szyszko T, Grantham M, Sagoo MS, Cohen VM.

Br J Ophthalmol. 2014 Dec;98(12):1659-65. doi: 10.1136/bjophthalmol-2014-305304. Epub 2014 Aug 1.

20.

Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.

Häusler T, Stang A, Anastassiou G, Jöckel KH, Mrzyk S, Horsthemke B, Lohmann DR, Zeschnigk M.

Int J Cancer. 2005 Oct 10;116(6):909-13.

Supplemental Content

Support Center